Efficacy and tolerability of baclofen in substance use disorders: a systematic review.

@article{Agabio2013EfficacyAT,
  title={Efficacy and tolerability of baclofen in substance use disorders: a systematic review.},
  author={R Agabio and Antonio Preti and Gian Luigi Gessa},
  journal={European addiction research},
  year={2013},
  volume={19 6},
  pages={325-45}
}
BACKGROUND It has been reported that baclofen, a drug used in the treatment of spasticity, reduces the severity of withdrawal symptoms and substance use disorders (SUDs) for some psychoactive drugs. AIMS AND METHODS To evaluate the effectiveness and safety of baclofen in the treatment of withdrawal syndrome and/or SUDs, providing (1) an outline of its pharmacological features; (2) a summary of studies that have suggested its possible effectiveness in the treatment of SUDs, and (3) a review of… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 1 time. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 14 extracted citations

Baclofen and γ-hydroxybutyrate (GHB), a dangerous combination.

Journal of addiction medicine • 2015
View 3 Excerpts
Highly Influenced

References

Publications referenced by this paper.
Showing 1-10 of 142 references

Baclofen for alcohol withdrawal.

The Cochrane database of systematic reviews • 2015

Similar Papers

Loading similar papers…